CTEV (Claritev) Other Long Term Assets: $36.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CTEV Claritev Corp CTEV
66 GF Score
Price $35.32
GF Value $28.43
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Claritev Other Long Term Assets?

Claritev CTEV +1.03% 66 Other Long Term Assets is $36.2 Mil as of Jun. 2026. GuruFocus rates CTEV with a GF Score™ of 66/100 and a GF Value™ of $28.43 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Claritev's other long-term assets for the quarter that ended in Jun. 2026 was $36.2 Mil.

Claritev's quarterly other long-term assets increased from Dec. 2025 ($33.3 Mil) to Mar. 2026 ($35.3 Mil) and increased from Mar. 2026 ($35.3 Mil) to Jun. 2026 ($36.2 Mil).

Claritev's annual other long-term assets increased from Dec. 2023 ($21.8 Mil) to Dec. 2024 ($37.1 Mil) but then declined from Dec. 2024 ($37.1 Mil) to Dec. 2025 ($33.3 Mil).

Claritev Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Claritev's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Claritev Other Long Term Assets Chart

Claritev Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial 9.70 21.90 21.78 37.10 33.34

Claritev Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.91 31.00 33.34 35.34 36.21
CTEV
66GF Score
Claritev Corp CTEV
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Claritev Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $36.2 Mil mean?
Claritev (CTEV) has a Other Long Term Assets of $36.2 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Claritev and its competitors.
Is Claritev's Other Long Term Assets too high?
Claritev's current Other Long Term Assets is $36.2 Mil. Overall, Claritev has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Claritev's Other Long Term Assets compare to SLP and TBRG?
Claritev's Other Long Term Assets of $36.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Claritev and its competitors. Claritev's current Other Long Term Assets is $36.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Claritev stock overvalued right now?
Based on GuruFocus' analysis, Claritev (CTEV) is currently considered Modestly Overvalued. The stock's GF Value™ is $28.43, compared to a current price of $35.32 — trading 24.2% above its estimated fair value. The current Other Long Term Assets is $36.2 Mil. Claritev's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Claritev (CTEV), the current Other Long Term Assets is $36.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Claritev (CTEV) Overvalued in 2026?

Based on GuruFocus' analysis, Claritev stock appears to be overvalued. The current stock price of $35.32 is trading 24.2% above its estimated GF Value™ of $28.43. GuruFocus considers Claritev to be Modestly Overvalued.

Key valuation signals for CTEV:

  • Other Long Term Assets: $36.2 Mil
  • GF Value™: $28.43 vs. price of $35.32 (24.2% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the CTEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Claritev Business Description

Address 7900 Tysons One Place, Suite 400, McLean, VA, USA, 22102
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
66GF Score

Get the complete analysis for CTEV

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$35.32
Price
$28.43
GF Value